SEVERE PREECLAMPSIA AND ECLAMPSIA: CRITICAL CONDITIONS FOR THE MOTHER AND FETUS
- Авторлар: SIDOROVA I.S1, MILOVANOV A.P2, NIKITINA N.A1, BARDACHOVA A.V1, RZAEVA A.A1
-
Мекемелер:
- I.M. Sechenov First Moscow State Medical University
- Research Institute of Human Morphology, Russian Academy of Medical Sciences
- Шығарылым: № 12 (2013)
- Беттер: 34-40
- Бөлім: Articles
- URL: https://journals.eco-vector.com/0300-9092/article/view/247076
- ID: 247076
Дәйексөз келтіру
Аннотация
Негізгі сөздер
Толық мәтін
![Рұқсат жабық](https://journals.eco-vector.com/lib/pkp/templates/images/icons/text_lock.png)
Авторлар туралы
I. SIDOROVA
I.M. Sechenov First Moscow State Medical UniversityObstetrics and Gynecology Department One, Faculty of Therapeutics
A. MILOVANOV
Research Institute of Human Morphology, Russian Academy of Medical SciencesLaboratory for Pathology of the Female Reproductive System
N. NIKITINA
I.M. Sechenov First Moscow State Medical University
Email: natnikitina@list.ru
Obstetrics and Gynecology Department One, Faculty of Therapeutics
A. BARDACHOVA
I.M. Sechenov First Moscow State Medical UniversityObstetrics and Gynecology Department One, Faculty of Therapeutics
A. RZAEVA
I.M. Sechenov First Moscow State Medical UniversityObstetrics and Gynecology Department One, Faculty of Therapeutics
Әдебиет тізімі
- Ghulmiyyah L., Sibai B. Maternal mortality from preeclampsia/eclampsia. Semin. Perinatol. 2012; 36(1): 56-9.
- ВОЗ. Материнская смертность. Информационный бюллетень N348, май 2012 г. Available at: http://www.who.int/ mediacentre/factsheets/fs348/ru/index.html.
- World Health Organization. WHO recommendations for prevention and treatment of pre-eclampsia and eclampsia. Geneva: WHO; 2011. 38 p.
- Макаров О.В., Ткачева О.Н., Волкова Е.В. Преэклампсия и хроническая артериальная гипертензия. Клинические аспекты. М.: ГЭОТАР-Медиа; 2010. 136 с.
- Стародубов В.И., Суханова Л.П. Репродуктивные проблемы демографического развития России. М.: Менеджер здравоохранения; 2012. 320 с.
- Liu S., Joseph K.S., Liston R.M., Bartholomew S., Walker M., Leon J.A. et al.; Maternal Health Study Group of Canadian Perinatal Surveillance System (Public Health Agency of Canada). Incidence, risk factors, and associated complications of eclampsia. Obstet. Gynecol. 2011; 118(5): 987-94.
- Bellamy L, Casas J.P., Hingorani A.D., Williams D.J. Preeclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. Br. Med. J. 2007; 335(7627): 974-7.
- Lazdam M., Davis E.F., Lewandowski A.J., Worton S.A., Kenworthy Y., Kelly B, Leeson P. Prevention of vascular dysfunction after preeclampsia: a potential long-term outcome measure and an emerging goal for treatment. J. Pregnancy. 2012; 2012: 704146.
- Uzan J., Carbonnel M., Piconne О., Asmar R., Ayoubi J.-M. Pre-eclampsia: pathophysiology, diagnosis and management. Vasc. Health Risk Manag. 2011; 7: 467-74.
- George E.M., Granger J.P. Endothelin: key mediator of hypertension in preeclampsia. Am. J. Hypertens. 2011; 24(9): 964-9.
- Kvehaugen A.S., Dechend R., Ramstad H.B., Troisi R, Fugelseth D., Staff A.C. Endothelial function and circulating biomarkers are disturbed in women and children after preeclampsia. Hypertension. 2011; 58(1): 63-9.
- Lamarca B. Endothelial dysfunction. An important mediator in the pathophysiology of hypertension during pre-eclampsia. Minerva Ginecol. 2012; 64(4): 309-20.
- Marusic J., Prusac I.K., Tomas S.Z., Karara J.R., Roje D. Expression of inflammatory cytokines in placentas from pregnancies complicated with preeclampsia and HELLP syndrome. J. Matern. Fetal Neonatal Med. 2013; 26(7): 680-5.
- Sezer S.D., Kugttk M., Yenisey C., Yuksel H., Odabap A.R., Ttirkmen M.K. et al. Comparison of angiogenic and anti-angiogenic factors in maternal and umbilical cord blood in early-and late-onset pre-eclampsia. Gynecol. Endocrinol. 2012; 28(8): 628-32.
- Soto E., Romero R., Kusanovic J.P., Ogge G., Hussein Y., Yeo L. et al. Late-onset preeclampsia is associated with an imbalance of angiogenic and anti-angiogenic factors in patients with and without placental lesions consistent with maternal underperfusion J. Matern. Fetal Neonatal Med. 2012; 25(5): 498-507.
- Burger D., Touyz R.M. Cellular biomarkers of endothelial health: microparticles, endothelial progenitor cells, and circulating endothelial cells. J. Am. Soc. Hypertens. 2012; 6(2): 85-99.
- Чехонин В.П., Дмитриева Т.Б., Жирков Ю.А. Иммунохимический анализ нейроспецифических антигенов. М.: Медицина; 2000. 416 с.
- Brewer J., Owens M.Y., Wallace K., Reeves A.A., Morris R, Khan M. et al. Posterior reversible encephalopathy syndrome in 46 of 47 patients with eclampsia. Am. J. Obstet. Gynecol. 2013; 208(6): 468, e1-6.
- Golombeck S.K., Wessig C., Monoranu C.M., Schutz A., Solymosi L., Melzer N., Kleinschnitz C. Fatal atypical reversible posterior leukoencephalopathy syndrome: a case report. J. Med. Case Rep. 2013; 7(1): 14.
- Шифман Е.М. Преэклампсия. Эклампсия. HELLP-синдром. Петрозаводск: ИнтелТек; 2002. 430 с.
- Cipolla M.J. Cerebrovascular function in pregnancy and eclampsia. Hypertension. 2007; 50: 14-24.
Қосымша файлдар
![](/img/style/loading.gif)